Industry Research Reports

Home > Reports > Pharma & Healthcare > Cold and Flu Supplement - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Cold and Flu Supplement - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Industry: Pharma & Healthcare

Published: 2024-01-11

Pages: 111 Pages

Report ld: 2622635

Description
Table of Contents
Table of Figures
PDF Download

Description
Table of Contents
Table of Figures
PDF Download

Description

Demand for cold and flu supplements has been increasing among the consumers in order to boost immunity and prevent the occurrences of such diseases. Cold and flu supplements are primarily consumed to enhance the immunity system of the individual. Cold and flu supplements are available in different forms, among them tablet and capsule are the most popular forms.

The global market for Cold and Flu Supplement was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

North American market for Cold and Flu Supplement was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Cold and Flu Supplement was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Europe market for Cold and Flu Supplement was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global key companies of Cold and Flu Supplement include Wakunaga of America, Neurobiologix, The Vitamin Shoppe, Klaire Labs, Nordic Naturals, Himalaya Global Holdings, Dr. Willmar Schwabe GmbH, FineVine and Flora, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Cold and Flu Supplement, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Cold and Flu Supplement by region & country, by Type, and by Application.

The Cold and Flu Supplement market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cold and Flu Supplement.

Market Segmentation

Report Metric
Details
Report Title
Cold and Flu Supplement - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Global Cold and Flu Supplement Companies Covered
Wakunaga of America, Neurobiologix, The Vitamin Shoppe, Klaire Labs, Nordic Naturals, Himalaya Global Holdings, Dr. Willmar Schwabe GmbH, FineVine, Flora, Pfizer, GlaxoSmithKline, NOW Foods
Global Cold and Flu Supplement Market, by Region
North America (U.S., Canada, Mexico)

Europe (Germany, France, UK, Italy, etc.)

Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

South America (Brazil, etc.)

Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Cold and Flu Supplement Market, Segment by Type
Natural Molecules

Herbal Extracts

Vitamins and Minerals

Others
Global Cold and Flu Supplement Market, Segment by Application
Online

Offline
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Cold and Flu Supplement manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Cold and Flu Supplement in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Cold and Flu Supplement in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Table of Contents

 1 Market Overview
    1.1 Cold and Flu Supplement Product Introduction
    1.2 Global Cold and Flu Supplement Market Size Forecast
    1.3 Cold and Flu Supplement Market Trends & Drivers
        1.3.1 Cold and Flu Supplement Industry Trends
        1.3.2 Cold and Flu Supplement Market Drivers & Opportunity
        1.3.3 Cold and Flu Supplement Market Challenges
        1.3.4 Cold and Flu Supplement Market Restraints
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

 2 Competitive Analysis by Company
    2.1 Global Cold and Flu Supplement Players Revenue Ranking (2023)
    2.2 Global Cold and Flu Supplement Revenue by Company (2019-2024)
    2.3 Key Companies Cold and Flu Supplement Manufacturing Base Distribution and Headquarters
    2.4 Key Companies Cold and Flu Supplement Product Offered
    2.5 Key Companies Time to Begin Mass Production of Cold and Flu Supplement
    2.6 Cold and Flu Supplement Market Competitive Analysis
        2.6.1 Cold and Flu Supplement Market Concentration Rate (2019-2024)
        2.6.2 Global 5 and 10 Largest Companies by Cold and Flu Supplement Revenue in 2023
        2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cold and Flu Supplement as of 2023)
    2.7 Mergers & Acquisitions, Expansion

 3 Segmentation by Type
    3.1 Introduction by Type
        3.1.1 Natural Molecules
        3.1.2 Herbal Extracts
        3.1.3 Vitamins and Minerals
        3.1.4 Others
    3.2 Global Cold and Flu Supplement Sales Value by Type
        3.2.1 Global Cold and Flu Supplement Sales Value by Type (2019 VS 2023 VS 2030)
        3.2.2 Global Cold and Flu Supplement Sales Value, by Type (2019-2030)
        3.2.3 Global Cold and Flu Supplement Sales Value, by Type (%) (2019-2030)

 4 Segmentation by Application
    4.1 Introduction by Application
        4.1.1 Online
        4.1.2 Offline
    4.2 Global Cold and Flu Supplement Sales Value by Application
        4.2.1 Global Cold and Flu Supplement Sales Value by Application (2019 VS 2023 VS 2030)
        4.2.2 Global Cold and Flu Supplement Sales Value, by Application (2019-2030)
        4.2.3 Global Cold and Flu Supplement Sales Value, by Application (%) (2019-2030)

 5 Segmentation by Region
    5.1 Global Cold and Flu Supplement Sales Value by Region
        5.1.1 Global Cold and Flu Supplement Sales Value by Region: 2019 VS 2023 VS 2030
        5.1.2 Global Cold and Flu Supplement Sales Value by Region (2019-2024)
        5.1.3 Global Cold and Flu Supplement Sales Value by Region (2025-2030)
        5.1.4 Global Cold and Flu Supplement Sales Value by Region (%), (2019-2030)
    5.2 North America
        5.2.1 North America Cold and Flu Supplement Sales Value, 2019-2030
        5.2.2 North America Cold and Flu Supplement Sales Value by Country (%), 2023 VS 2030
    5.3 Europe
        5.3.1 Europe Cold and Flu Supplement Sales Value, 2019-2030
        5.3.2 Europe Cold and Flu Supplement Sales Value by Country (%), 2023 VS 2030
    5.4 Asia Pacific
        5.4.1 Asia Pacific Cold and Flu Supplement Sales Value, 2019-2030
        5.4.2 Asia Pacific Cold and Flu Supplement Sales Value by Country (%), 2023 VS 2030
    5.5 South America
        5.5.1 South America Cold and Flu Supplement Sales Value, 2019-2030
        5.5.2 South America Cold and Flu Supplement Sales Value by Country (%), 2023 VS 2030
    5.6 Middle East & Africa
        5.6.1 Middle East & Africa Cold and Flu Supplement Sales Value, 2019-2030
        5.6.2 Middle East & Africa Cold and Flu Supplement Sales Value by Country (%), 2023 VS 2030

 6 Segmentation by Key Countries/Regions
    6.1 Key Countries/Regions Cold and Flu Supplement Sales Value Growth Trends, 2019 VS 2023 VS 2030
    6.2 Key Countries/Regions Cold and Flu Supplement Sales Value
    6.3 United States
        6.3.1 United States Cold and Flu Supplement Sales Value, 2019-2030
        6.3.2 United States Cold and Flu Supplement Sales Value by Type (%), 2023 VS 2030
        6.3.3 United States Cold and Flu Supplement Sales Value by Application, 2023 VS 2030
    6.4 Europe
        6.4.1 Europe Cold and Flu Supplement Sales Value, 2019-2030
        6.4.2 Europe Cold and Flu Supplement Sales Value by Type (%), 2023 VS 2030
        6.4.3 Europe Cold and Flu Supplement Sales Value by Application, 2023 VS 2030
    6.5 China
        6.5.1 China Cold and Flu Supplement Sales Value, 2019-2030
        6.5.2 China Cold and Flu Supplement Sales Value by Type (%), 2023 VS 2030
        6.5.3 China Cold and Flu Supplement Sales Value by Application, 2023 VS 2030
    6.6 Japan
        6.6.1 Japan Cold and Flu Supplement Sales Value, 2019-2030
        6.6.2 Japan Cold and Flu Supplement Sales Value by Type (%), 2023 VS 2030
        6.6.3 Japan Cold and Flu Supplement Sales Value by Application, 2023 VS 2030
    6.7 South Korea
        6.7.1 South Korea Cold and Flu Supplement Sales Value, 2019-2030
        6.7.2 South Korea Cold and Flu Supplement Sales Value by Type (%), 2023 VS 2030
        6.7.3 South Korea Cold and Flu Supplement Sales Value by Application, 2023 VS 2030
    6.8 Southeast Asia
        6.8.1 Southeast Asia Cold and Flu Supplement Sales Value, 2019-2030
        6.8.2 Southeast Asia Cold and Flu Supplement Sales Value by Type (%), 2023 VS 2030
        6.8.3 Southeast Asia Cold and Flu Supplement Sales Value by Application, 2023 VS 2030
    6.9 India
        6.9.1 India Cold and Flu Supplement Sales Value, 2019-2030
        6.9.2 India Cold and Flu Supplement Sales Value by Type (%), 2023 VS 2030
        6.9.3 India Cold and Flu Supplement Sales Value by Application, 2023 VS 2030

 7 Company Profiles
    7.1 Wakunaga of America
        7.1.1 Wakunaga of America Profile
        7.1.2 Wakunaga of America Main Business
        7.1.3 Wakunaga of America Cold and Flu Supplement Products, Services and Solutions
        7.1.4 Wakunaga of America Cold and Flu Supplement Revenue (US$ Million) & (2019-2024)
        7.1.5 Wakunaga of America Recent Developments
    7.2 Neurobiologix
        7.2.1 Neurobiologix Profile
        7.2.2 Neurobiologix Main Business
        7.2.3 Neurobiologix Cold and Flu Supplement Products, Services and Solutions
        7.2.4 Neurobiologix Cold and Flu Supplement Revenue (US$ Million) & (2019-2024)
        7.2.5 Neurobiologix Recent Developments
    7.3 The Vitamin Shoppe
        7.3.1 The Vitamin Shoppe Profile
        7.3.2 The Vitamin Shoppe Main Business
        7.3.3 The Vitamin Shoppe Cold and Flu Supplement Products, Services and Solutions
        7.3.4 The Vitamin Shoppe Cold and Flu Supplement Revenue (US$ Million) & (2019-2024)
        7.3.5 Klaire Labs Recent Developments
    7.4 Klaire Labs
        7.4.1 Klaire Labs Profile
        7.4.2 Klaire Labs Main Business
        7.4.3 Klaire Labs Cold and Flu Supplement Products, Services and Solutions
        7.4.4 Klaire Labs Cold and Flu Supplement Revenue (US$ Million) & (2019-2024)
        7.4.5 Klaire Labs Recent Developments
    7.5 Nordic Naturals
        7.5.1 Nordic Naturals Profile
        7.5.2 Nordic Naturals Main Business
        7.5.3 Nordic Naturals Cold and Flu Supplement Products, Services and Solutions
        7.5.4 Nordic Naturals Cold and Flu Supplement Revenue (US$ Million) & (2019-2024)
        7.5.5 Nordic Naturals Recent Developments
    7.6 Himalaya Global Holdings
        7.6.1 Himalaya Global Holdings Profile
        7.6.2 Himalaya Global Holdings Main Business
        7.6.3 Himalaya Global Holdings Cold and Flu Supplement Products, Services and Solutions
        7.6.4 Himalaya Global Holdings Cold and Flu Supplement Revenue (US$ Million) & (2019-2024)
        7.6.5 Himalaya Global Holdings Recent Developments
    7.7 Dr. Willmar Schwabe GmbH
        7.7.1 Dr. Willmar Schwabe GmbH Profile
        7.7.2 Dr. Willmar Schwabe GmbH Main Business
        7.7.3 Dr. Willmar Schwabe GmbH Cold and Flu Supplement Products, Services and Solutions
        7.7.4 Dr. Willmar Schwabe GmbH Cold and Flu Supplement Revenue (US$ Million) & (2019-2024)
        7.7.5 Dr. Willmar Schwabe GmbH Recent Developments
    7.8 FineVine
        7.8.1 FineVine Profile
        7.8.2 FineVine Main Business
        7.8.3 FineVine Cold and Flu Supplement Products, Services and Solutions
        7.8.4 FineVine Cold and Flu Supplement Revenue (US$ Million) & (2019-2024)
        7.8.5 FineVine Recent Developments
    7.9 Flora
        7.9.1 Flora Profile
        7.9.2 Flora Main Business
        7.9.3 Flora Cold and Flu Supplement Products, Services and Solutions
        7.9.4 Flora Cold and Flu Supplement Revenue (US$ Million) & (2019-2024)
        7.9.5 Flora Recent Developments
    7.10 Pfizer
        7.10.1 Pfizer Profile
        7.10.2 Pfizer Main Business
        7.10.3 Pfizer Cold and Flu Supplement Products, Services and Solutions
        7.10.4 Pfizer Cold and Flu Supplement Revenue (US$ Million) & (2019-2024)
        7.10.5 Pfizer Recent Developments
    7.11 GlaxoSmithKline
        7.11.1 GlaxoSmithKline Profile
        7.11.2 GlaxoSmithKline Main Business
        7.11.3 GlaxoSmithKline Cold and Flu Supplement Products, Services and Solutions
        7.11.4 GlaxoSmithKline Cold and Flu Supplement Revenue (US$ Million) & (2019-2024)
        7.11.5 GlaxoSmithKline Recent Developments
    7.12 NOW Foods
        7.12.1 NOW Foods Profile
        7.12.2 NOW Foods Main Business
        7.12.3 NOW Foods Cold and Flu Supplement Products, Services and Solutions
        7.12.4 NOW Foods Cold and Flu Supplement Revenue (US$ Million) & (2019-2024)
        7.12.5 NOW Foods Recent Developments

 8 Industry Chain Analysis
    8.1 Cold and Flu Supplement Industrial Chain
    8.2 Cold and Flu Supplement Upstream Analysis
        8.2.1 Key Raw Materials
        8.2.2 Raw Materials Key Suppliers
        8.2.3 Manufacturing Cost Structure
    8.3 Midstream Analysis
    8.4 Downstream Analysis (Customers Analysis)
    8.5 Sales Model and Sales Channels
        8.5.1 Cold and Flu Supplement Sales Model
        8.5.2 Sales Channel
        8.5.3 Cold and Flu Supplement Distributors

 9 Research Findings and Conclusion

 10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Cold and Flu Supplement Market Trends
    Table 2. Cold and Flu Supplement Market Drivers & Opportunity
    Table 3. Cold and Flu Supplement Market Challenges
    Table 4. Cold and Flu Supplement Market Restraints
    Table 5. Global Cold and Flu Supplement Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Cold and Flu Supplement Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Cold and Flu Supplement Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Cold and Flu Supplement Product Type
    Table 9. Key Companies Time to Begin Mass Production of Cold and Flu Supplement
    Table 10. Global Cold and Flu Supplement Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cold and Flu Supplement as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Cold and Flu Supplement Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Cold and Flu Supplement Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Cold and Flu Supplement Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Cold and Flu Supplement Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Cold and Flu Supplement Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Cold and Flu Supplement Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Cold and Flu Supplement Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Cold and Flu Supplement Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Cold and Flu Supplement Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Cold and Flu Supplement Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Cold and Flu Supplement Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Cold and Flu Supplement Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Cold and Flu Supplement Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Cold and Flu Supplement Sales Value by Region (2019-2024) & (%)
    Table 27. Global Cold and Flu Supplement Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Cold and Flu Supplement Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Cold and Flu Supplement Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Cold and Flu Supplement Sales Value, (2025-2030) & (US$ Million)
    Table 31. Wakunaga of America Basic Information List
    Table 32. Wakunaga of America Description and Business Overview
    Table 33. Wakunaga of America Cold and Flu Supplement Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Cold and Flu Supplement Business of Wakunaga of America (2019-2024)
    Table 35. Wakunaga of America Recent Developments
    Table 36. Neurobiologix Basic Information List
    Table 37. Neurobiologix Description and Business Overview
    Table 38. Neurobiologix Cold and Flu Supplement Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Cold and Flu Supplement Business of Neurobiologix (2019-2024)
    Table 40. Neurobiologix Recent Developments
    Table 41. The Vitamin Shoppe Basic Information List
    Table 42. The Vitamin Shoppe Description and Business Overview
    Table 43. The Vitamin Shoppe Cold and Flu Supplement Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Cold and Flu Supplement Business of The Vitamin Shoppe (2019-2024)
    Table 45. The Vitamin Shoppe Recent Developments
    Table 46. Klaire Labs Basic Information List
    Table 47. Klaire Labs Description and Business Overview
    Table 48. Klaire Labs Cold and Flu Supplement Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Cold and Flu Supplement Business of Klaire Labs (2019-2024)
    Table 50. Klaire Labs Recent Developments
    Table 51. Nordic Naturals Basic Information List
    Table 52. Nordic Naturals Description and Business Overview
    Table 53. Nordic Naturals Cold and Flu Supplement Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Cold and Flu Supplement Business of Nordic Naturals (2019-2024)
    Table 55. Nordic Naturals Recent Developments
    Table 56. Himalaya Global Holdings Basic Information List
    Table 57. Himalaya Global Holdings Description and Business Overview
    Table 58. Himalaya Global Holdings Cold and Flu Supplement Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Cold and Flu Supplement Business of Himalaya Global Holdings (2019-2024)
    Table 60. Himalaya Global Holdings Recent Developments
    Table 61. Dr. Willmar Schwabe GmbH Basic Information List
    Table 62. Dr. Willmar Schwabe GmbH Description and Business Overview
    Table 63. Dr. Willmar Schwabe GmbH Cold and Flu Supplement Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Cold and Flu Supplement Business of Dr. Willmar Schwabe GmbH (2019-2024)
    Table 65. Dr. Willmar Schwabe GmbH Recent Developments
    Table 66. FineVine Basic Information List
    Table 67. FineVine Description and Business Overview
    Table 68. FineVine Cold and Flu Supplement Products, Services and Solutions
    Table 69. Revenue (US$ Million) in Cold and Flu Supplement Business of FineVine (2019-2024)
    Table 70. FineVine Recent Developments
    Table 71. Flora Basic Information List
    Table 72. Flora Description and Business Overview
    Table 73. Flora Cold and Flu Supplement Products, Services and Solutions
    Table 74. Revenue (US$ Million) in Cold and Flu Supplement Business of Flora (2019-2024)
    Table 75. Flora Recent Developments
    Table 76. Pfizer Basic Information List
    Table 77. Pfizer Description and Business Overview
    Table 78. Pfizer Cold and Flu Supplement Products, Services and Solutions
    Table 79. Revenue (US$ Million) in Cold and Flu Supplement Business of Pfizer (2019-2024)
    Table 80. Pfizer Recent Developments
    Table 81. GlaxoSmithKline Basic Information List
    Table 82. GlaxoSmithKline Description and Business Overview
    Table 83. GlaxoSmithKline Cold and Flu Supplement Products, Services and Solutions
    Table 84. Revenue (US$ Million) in Cold and Flu Supplement Business of GlaxoSmithKline (2019-2024)
    Table 85. GlaxoSmithKline Recent Developments
    Table 86. NOW Foods Basic Information List
    Table 87. NOW Foods Description and Business Overview
    Table 88. NOW Foods Cold and Flu Supplement Products, Services and Solutions
    Table 89. Revenue (US$ Million) in Cold and Flu Supplement Business of NOW Foods (2019-2024)
    Table 90. NOW Foods Recent Developments
    Table 91. Key Raw Materials Lists
    Table 92. Raw Materials Key Suppliers Lists
    Table 93. Cold and Flu Supplement Downstream Customers
    Table 94. Cold and Flu Supplement Distributors List
    Table 95. Research Programs/Design for This Report
    Table 96. Key Data Information from Secondary Sources
    Table 97. Key Data Information from Primary Sources
    Table 98. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Cold and Flu Supplement Product Picture
    Figure 2. Global Cold and Flu Supplement Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Cold and Flu Supplement Sales Value (2019-2030) & (US$ Million)
    Figure 4. Cold and Flu Supplement Report Years Considered
    Figure 5. Global Cold and Flu Supplement Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Cold and Flu Supplement Revenue in 2023
    Figure 7. Cold and Flu Supplement Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Natural Molecules Picture
    Figure 9. Herbal Extracts Picture
    Figure 10. Vitamins and Minerals Picture
    Figure 11. Others Picture
    Figure 12. Global Cold and Flu Supplement Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 13. Global Cold and Flu Supplement Sales Value Market Share by Type, 2023 & 2030
    Figure 14. Product Picture of Online
    Figure 15. Product Picture of Offline
    Figure 16. Global Cold and Flu Supplement Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 17. Global Cold and Flu Supplement Sales Value Market Share by Application, 2023 & 2030
    Figure 18. North America Cold and Flu Supplement Sales Value (2019-2030) & (US$ Million)
    Figure 19. North America Cold and Flu Supplement Sales Value by Country (%), 2023 VS 2030
    Figure 20. Europe Cold and Flu Supplement Sales Value (2019-2030) & (US$ Million)
    Figure 21. Europe Cold and Flu Supplement Sales Value by Country (%), 2023 VS 2030
    Figure 22. Asia Pacific Cold and Flu Supplement Sales Value (2019-2030) & (US$ Million)
    Figure 23. Asia Pacific Cold and Flu Supplement Sales Value by Country (%), 2023 VS 2030
    Figure 24. South America Cold and Flu Supplement Sales Value (2019-2030) & (US$ Million)
    Figure 25. South America Cold and Flu Supplement Sales Value by Country (%), 2023 VS 2030
    Figure 26. Middle East & Africa Cold and Flu Supplement Sales Value (2019-2030) & (US$ Million)
    Figure 27. Middle East & Africa Cold and Flu Supplement Sales Value by Country (%), 2023 VS 2030
    Figure 28. Key Countries/Regions Cold and Flu Supplement Sales Value (%), (2019-2030)
    Figure 29. United States Cold and Flu Supplement Sales Value, (2019-2030) & (US$ Million)
    Figure 30. United States Cold and Flu Supplement Sales Value by Type (%), 2023 VS 2030
    Figure 31. United States Cold and Flu Supplement Sales Value by Application (%), 2023 VS 2030
    Figure 32. Europe Cold and Flu Supplement Sales Value, (2019-2030) & (US$ Million)
    Figure 33. Europe Cold and Flu Supplement Sales Value by Type (%), 2023 VS 2030
    Figure 34. Europe Cold and Flu Supplement Sales Value by Application (%), 2023 VS 2030
    Figure 35. China Cold and Flu Supplement Sales Value, (2019-2030) & (US$ Million)
    Figure 36. China Cold and Flu Supplement Sales Value by Type (%), 2023 VS 2030
    Figure 37. China Cold and Flu Supplement Sales Value by Application (%), 2023 VS 2030
    Figure 38. Japan Cold and Flu Supplement Sales Value, (2019-2030) & (US$ Million)
    Figure 39. Japan Cold and Flu Supplement Sales Value by Type (%), 2023 VS 2030
    Figure 40. Japan Cold and Flu Supplement Sales Value by Application (%), 2023 VS 2030
    Figure 41. South Korea Cold and Flu Supplement Sales Value, (2019-2030) & (US$ Million)
    Figure 42. South Korea Cold and Flu Supplement Sales Value by Type (%), 2023 VS 2030
    Figure 43. South Korea Cold and Flu Supplement Sales Value by Application (%), 2023 VS 2030
    Figure 44. Southeast Asia Cold and Flu Supplement Sales Value, (2019-2030) & (US$ Million)
    Figure 45. Southeast Asia Cold and Flu Supplement Sales Value by Type (%), 2023 VS 2030
    Figure 46. Southeast Asia Cold and Flu Supplement Sales Value by Application (%), 2023 VS 2030
    Figure 47. India Cold and Flu Supplement Sales Value, (2019-2030) & (US$ Million)
    Figure 48. India Cold and Flu Supplement Sales Value by Type (%), 2023 VS 2030
    Figure 49. India Cold and Flu Supplement Sales Value by Application (%), 2023 VS 2030
    Figure 50. Cold and Flu Supplement Industrial Chain
    Figure 51. Cold and Flu Supplement Manufacturing Cost Structure
    Figure 52. Channels of Distribution (Direct Sales, and Distribution)
    Figure 53. Bottom-up and Top-down Approaches for This Report
    Figure 54. Data Triangulation

Description

Demand for cold and flu supplements has been increasing among the consumers in order to boost immunity and prevent the occurrences of such diseases. Cold and flu supplements are primarily consumed to enhance the immunity system of the individual. Cold and flu supplements are available in different forms, among them tablet and capsule are the most popular forms.

The global market for Cold and Flu Supplement was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

North American market for Cold and Flu Supplement was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Cold and Flu Supplement was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Europe market for Cold and Flu Supplement was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Market Segmentation